,127 Patel et al showed that in CML LSCs, a BCR-ABL–independent STAT3 program resulted in dysregulated mitochondrial metabolism, ultimately leading to TKI-persistent LSCs being dependent on glycolysis and thus, sensitive to glycolytic inhibition.72 Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.